Your shopping cart is currently empty

CCG-271423 is a potent and selective inhibitor of GRK5, demonstrating activity against GRK5 (IC50: 0.0021 μM) and GRK2 (IC50: 44 μM); it reduces Ca2+ transients and inhibits cardiomyocyte contractility.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | CCG-271423 is a potent and selective inhibitor of GRK5, demonstrating activity against GRK5 (IC50: 0.0021 μM) and GRK2 (IC50: 44 μM); it reduces Ca2+ transients and inhibits cardiomyocyte contractility. |
| Molecular Weight | 466.53 |
| Formula | C28H26N4O3 |
| Cas No. | 2750413-88-6 |
| Smiles | C(=C\1/C=2C(NC1=O)=CC=C(C(N[C@H](C)C3=CC=CC=C3)=O)C2)\C4=C(C)C(C(NCC#C)=O)=C(C)N4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.